Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism

European Respiratory Journal

Volumn 34, Issue 6, 2009, Pages 1357-1363

  Janata, K M ^a   Leitner, J M ^a   Holzer Richling, N ^a   Janata, A ^a   Laggner, A N ^a   Jilma, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Prognosis; Pulmonary embolism; Troponin

Indexed keywords

CATECHOLAMINE; FIBRINOLYTIC AGENT; TROPONIN T;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EMERGENCY SERVICE, HOSPITAL; FEMALE; HEMODYNAMICS; HUMANS; IMMUNOASSAY; LUMINESCENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; PULMONARY EMBOLISM; TREATMENT OUTCOME; TROPONIN T;

EID: 73249128842     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00033109     Document Type: Article

References (23)

1. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005; 142: 786-791.
2. Kucher N, Rossi E, De Rosa M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mmHg or higher. Arch Intern Med 2005; 165: 1777-1781.
3. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
4. Becattini C, Vedovati MC, Agnelli G. Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins. Expert Rev Mol Diagn 2008; 8: 339-349.
5. Jimenez D, Diaz G, Molina J, et al. Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism. Eur Respir J 2008; 31: 847-853.
6. Capstick T, Henry MT. Efficacy of thrombolytic agents in the treatment of pulmonary embolism. Eur Respir J 2005; 26: 864-874.
7. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427-433.
8. Janata K, Holzer M, Laggner AN, et al. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. BMJ 2003; 326: 312-313.
9. Nijkeuter M, Sohne M, Tick LW, et al. The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study. Chest 2007; 131: 517-523.
10. Laporte S, Mismetti P, Decousus H, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117: 1711-1716.
11. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211-217.
12. Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 2003; 123: 1947-1952.
13. Bova C, Crocco F, Ricchio R, et al. Importance of troponin T for the risk stratification of normotensive patients with pulmonary embolism. A prospective, cohort study with a three-month follow-up. Haematologica 2005; 90: 423-424.
14. Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 2005; 26: 2166-2172.
15. Kaczynska A, Pelsers MM, Bochowicz A, et al. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta 2006; 371: 117-123.
16. Kline JA, Hernandez-Nino J, Rose GA, et al. Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism. Crit Care Med 2006; 34: 2773-2780.
17. Tulevski II, ten Wolde M, van Veldhuisen DJ, et al. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol 2007; 116: 161-166.
18. Tapson VF, Huisman MV. Home at last? Early discharge for acute pulmonary embolism. Eur Respir J 2007; 30: 613-615.
19. Kozak LJ, DeFrances CJ, Hall MJ. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13, 2006: 1-209.
20. Aujesky D, Stone RA, Kim S, et al. Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective. Arch Intern Med 2008; 168: 706-712.
21. Hojs R. Cardiac troponin T in patients with kidney disease. Ther Apher Dial 2005; 9: 205-207.
22. Khan NA, Hemmelgarn BR, Tonelli M, et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088-3096.
23. Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 2000; 160: 1529-1535.